Tamarack Capital Management, LLC

Add to watchlist

$0 is the total value of Tamarack Capital Management, LLC's 0 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 103.1% .

All

			Value		Shares		↓ Weighting
	New	NAna	$0	–	0	+100.0%	0.00%	–
GMED	Exit	GLOBUS MEDICAL INC - A	$0	–	-45,000	-100.0%	-0.11%	–
NUVA	Exit	NUVASIVE INC	$0	–	-25,000	-100.0%	-0.14%	–
HRTX	Exit	HERON THERAPEUTICS INC	$0	–	-75,000	-100.0%	-0.22%	–
STRM	Exit	STREAMLINE HEALTH SOLUTIONS	$0	–	-1,138,000	-100.0%	-0.31%	–
LNTH	Exit	LANTHEUS HOLDINGS INC	$0	–	-615,000	-100.0%	-0.32%	–
CERS	Exit	CERUS CORP	$0	–	-900,000	-100.0%	-0.49%	–
OXFD	Exit	OXFORD IMMUNOTEC GLOBAL PLC	$0	–	-375,000	-100.0%	-0.60%	–
PRGO	Exit	PERRIGO CO PLC	$0	–	-50,000	-100.0%	-0.94%	–
SPNC	Exit	SPECTRANETICS CORP	$0	–	-785,000	-100.0%	-1.10%	–
AMGN	Exit	AMGEN INC	$0	–	-75,000	-100.0%	-1.24%	–
AMRN	Exit	AMARIN CORPORATION PLC -ADRadrs	$0	–	-5,700,000	-100.0%	-1.31%	–
RTIX	Exit	RTI SURGICAL INC	$0	–	-1,950,000	-100.0%	-1.32%	–
TEVA	Exit	TEVA PHARMACEUTICAL-SP ADRcall	$0	–	-200,000	-100.0%	-1.34%	–
CORI	Exit	CORIUM INTERNATIONAL INC	$0	–	-1,325,000	-100.0%	-1.48%	–
PRGO	Exit	PERRIGO CO PLCcall	$0	–	-80,000	-100.0%	-1.50%	–
BIO	Exit	BIO-RAD LABORATORIES-CL A	$0	–	-110,000	-100.0%	-1.76%	–
LMNX	Exit	LUMINEX CORP	$0	–	-950,000	-100.0%	-1.91%	–
ATRC	Exit	ATRICURE INC	$0	–	-825,000	-100.0%	-2.15%	–
MRK	Exit	MERCK & CO. INC.call	$0	–	-400,000	-100.0%	-2.35%	–
ALKS	Exit	ALKERMES PLC	$0	–	-365,000	-100.0%	-2.55%	–
IMPR	Exit	IMPRIVATA INC	$0	–	-1,425,000	-100.0%	-3.01%	–
MDRX	Exit	ALLSCRIPTS MISYS HEALTHCARE SOLUTIONS IN	$0	–	-2,150,000	-100.0%	-3.17%	–
NXTM	Exit	NXSTAGE MEDICAL INC	$0	–	-2,000,000	-100.0%	-3.75%	–
BDX	Exit	BECTON DICKINSON & CO	$0	–	-275,000	-100.0%	-4.34%	–
GB	Exit	GREATBATCH INC	$0	–	-700,000	-100.0%	-4.70%	–
DGX	Exit	QUEST DIAGNOSTICS	$0	–	-700,000	-100.0%	-5.12%	–
MDT	Exit	MEDTRONIC PLC	$0	–	-700,000	-100.0%	-5.58%	–
ELGX	Exit	ENDOLOGIX INC	$0	–	-4,050,000	-100.0%	-5.91%	–
PDCO	Exit	PATTERSON COS INC	$0	–	-1,225,000	-100.0%	-6.31%	–
IWM	Exit	ISHARES RUSSELL 2000put	$0	–	-600,000	-100.0%	-7.80%	–
TLT	Exit	ISHARES LEHMAN 20+ YR TREAScall	$0	–	-762,000	-100.0%	-11.20%	–
SPY	Exit	SPDR S&P 500 ETF TRUSTcall	$0	–	-700,000	-100.0%	-15.97%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2016-02-10

Signatures

The EDGAR filing(s) were signed by:

Andrew H. Fesler — Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
GREATBATCH INC	10	Q3 2015	9.2%
ALKERMES PLC	10	Q3 2015	8.8%
SPECTRANETICS CORP	10	Q3 2015	6.8%
ATRICURE INC	10	Q3 2015	4.6%
RTI SURGICAL INC	10	Q3 2015	4.6%
NXSTAGE MEDICAL INC	9	Q3 2015	3.8%
LUMINEX CORP	8	Q3 2015	2.4%
STREAMLINE HEALTH SOLUTIONS	8	Q3 2015	1.3%
SPDR S&P 500 ETF TRUST	7	Q2 2015	26.7%
ENDOLOGIX INC	7	Q3 2015	9.2%

View Tamarack Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

Tamarack Capital Management, LLC Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
ENDOLOGIX INC /DE/^{Sold out}	February 18, 2016	0	0.0%
STREAMLINE HEALTH SOLUTIONS INC.^{Sold out}	February 11, 2016	0	0.0%

View Tamarack Capital Management, LLC's complete significant-ownership history.

Latest filings

Type	Filed
4	2021-03-05
3	2019-10-25
SC 13G/A	2016-02-18
SC 13G/A	2016-02-11
SC 13G/A	2016-02-11
13F-HR	2016-02-10
13F-HR	2015-11-10
13F-HR	2015-08-11
13F-HR	2015-05-11
13F-HR	2015-02-11

View Tamarack Capital Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported number of holdings is incorrect (0 != 1)

Export Tamarack Capital Management, LLC's holdings

Tamarack Capital Management, LLC - Q4 2015 holdings